Bag6 appears to be a negative regulator in the innate immune system of non-small cell lung cancer patients [31, 32] and a risk factor for lung cancer [33, 34], even in early non-smoker lung adenocarcinoma patients [35]. Here, BAG6 is linked to non-small cell lung carcinoma.